The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy

被引：42

作者：

Gompel, A. ^{[1
]}

Rozenberg, S. ^{[2
]}

Barlow, D. H. ^{[3
]}

机构：

[1] Univ Paris 05, AP HP, Unite Gynecol Endocrinienne, Hotel Dieu Paris, F-75004 Paris, France

[2] Univ Libre Bruxelles, CHU ST Pierre, Dept Ob Gyn, B-1000 Brussels, Belgium

[3] Univ Glasgow, Wolfson Med Sch, Glasgow G12 8QQ, Lanark, Scotland

来源：

MATURITAS | 2008年 / 61卷 / 03期

关键词：

Menopause; Cardiovascular; Stroke; Venous thrombosis; Breast cancer; Ovarian cancer; Recommendations;

D O I：

10.1016/j.maturitas.2008.10.009

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Hormone therapy is still the most commonly used treatment to relieve Menopausal symptoms and the consequences of oestrogen deficiency. The decision process is complex and benefits needs to be balanced vs. risks. Not all reported benefits and risks have been as well highlighted by the media throughout recent years, it is therefore important to Update regularly the current scientific knowledge. This is an actualization of the last EMAS statement concerning hormone replacement therapy use. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：227 / 232

页数：6

共 33 条

[1] Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider [J].

Abenhaim, Haim A. ;

Titus-Ernstoff, Linda ;

Cramer, Daniel W. .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (07) :941-947

[2]

Allemand H, 2008, B CANCER, V95, P11, DOI 10.1684/bdc.2008.0556

[3]

[Anonymous], 2008, BREAST CANCER RES TR, DOI DOI 10.1007/s10549-007-9523-x

[4] Ovarian cancer and hormone replacement therapy in the Million Women Study [J].

Beral, Valerie ;

Bull, Diana ;

Green, Jane ;

Reeves, Gillian .

LANCET, 2007, 369 (9574) :1703-1710

[5] Hip bone density predicts breast cancer risk independently of gail score - Results from the women's health initiative [J].

Chen, Zhao ;

Arendell, Leslie ;

Aickin, Mikel ;

Cauley, Jane ;

Lewis, Cora E. ;

Chlebowski, Rowan ;

Nabel, Elizabeth ;

Rossouw, Jacques ;

Ludlam, Shari ;

Pottern, Linda ;

McGowan, Joan ;

Ford, Leslie ;

Geller, Nancy ;

Prentice, Ross ;

Anderson, Garnet ;

LaCroix, Andrea ;

Kooperberg, Charles L. ;

Patterson, Ruth E. ;

McTiernan, Anne ;

Shumaker, Sally ;

Stein, Evan ;

Cummings, Steven ;

Wassertheil-Smoller, Sylvia ;

Hays, Jennifer ;

Manson, Joann ;

Assaf, Annlouise R. ;

Phillips, Lawrence ;

Beresford, Shirley ;

Hsia, Judith ;

Chlebowski, Rowan ;

Whitlock, Evelyn ;

Caan, Bette ;

Howard, Barbara V. ;

Van Horn, Linda ;

Black, Henry ;

Stefanick, Marcia L. ;

Lane, Dorothy ;

Jackson, Rebecca ;

Lewis, Cora E. ;

Bassford, Tamsen ;

Wactawski-Wende, Jean ;

Robbins, John ;

Hubbell, F. Allan ;

Judd, Howard ;

Langer, Robert D. ;

Gass, Margery ;

Limacher, Marian ;

Curb, David ;

Wallace, Robert ;

Ockene, Judith .

CANCER, 2008, 113 (05) :907-915

[6] The effects of tibolone in older postmenopausal women [J].

Cummings, Steven R. ;

Ettinger, Bruce ;

Delmas, Pierre D. ;

Kenemans, Peter ;

Stathopoulos, Victoria ;

Verweij, Pierre ;

Mol-Arts, Mirjam ;

Kloosterboer, Lenus ;

Mosca, Lori ;

Christiansen, Claus ;

Bilezikian, John ;

Kerzberg, Eduardo Mario ;

Johnson, Susan ;

Zanchetta, Jose ;

Grobbee, Diederich E. ;

Seifert, Wilfried ;

Eastell, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (07) :697-708

[7] A prospective study of postmenopausal hormone use and ovarian cancer risk [J].

Danforth, K. N. ;

Tworoger, S. S. ;

Hecht, J. L. ;

Rosner, B. A. ;

Colditz, G. A. ;

Hankinson, S. E. .

BRITISH JOURNAL OF CANCER, 2007, 96 (01) :151-156

[8] Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer [J].

Fournier, Agnes ;

Fabre, Alban ;

Mesrine, Sylvie ;

Boutron-Ruault, Marie-Christine ;

Berrino, Franco ;

Clavel-Chapelon, Francoise .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1260-1268

[9] Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status [J].

Glass, Andrew G. ;

Lacey, James V., Jr. ;

Carreon, Daniel ;

Hoover, Robert N. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (15) :1152-1161

[10] The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy [J].

Gompel, Anne ;

Barlow, David ;

Rozenberg, Serge ;

Skouby, Sven O. .

MATURITAS, 2007, 56 (02) :227-229

← 1 2 3 4 →